Synthesis of 213Bi-DOTA-Substance P for targeted alpha-radionuclide therapy in patients with malignant glioma

被引：0
|
作者：
Bruchertseifer, F. [1 ]
Cordier, D. [2 ]
Forrer, F. [3 ]
Kneifel, S. [3 ]
Apostolidis, C. [1 ]
Morgenstern, A. [1 ]
Merlo, A. [2 ]
Maecke, H. R. [3 ]
机构：
[1] Commiss European Communities, Joint Res Ctr, Inst Transuranium Elements, D-7500 Karlsruhe, Germany
[2] Univ Basel Hosp, Neurosurg Clin, CH-4031 Basel, Switzerland
[3] Univ Basel Hosp, Clin & Inst Nucl Med, CH-4031 Basel, Switzerland
来源：
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS | 2008年 / 23卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
02
引用
收藏
页码：513 / 513
页数：1
相关论文
共 37 条
  • [1] Synthesis of 213Bi-DOTA-Substance P for Targeted Alpha-Radionuclide Therapy in Patients with Malignant Glioma
    Bruchertseifer, F.
    Cordier, D.
    Forrer, F.
    Kneifel, S.
    Apostolidis, C.
    Morgenstern, A.
    Merlo, A.
    Maecke, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S149 - S149
  • [2] Recurrent glioblastoma multiforme - targeted alpha therapy with 213Bi-DOTA-Substance P
    Krolicki, L.
    Krolicki, B.
    Morgenstern, A.
    Kunikowska, J.
    Koziara, H.
    Jakucinski, M.
    Apostolidis, C.
    Bruchertseifer, F.
    RADIOTHERAPY AND ONCOLOGY, 2016, 118 : S16 - S16
  • [3] Safety and efficacy of targeted alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastoma
    Leszek Królicki
    Frank Bruchertseifer
    Jolanta Kunikowska
    Henryk Koziara
    Bartosz Królicki
    Maciej Jakuciński
    Dariusz Pawlak
    Christos Apostolidis
    Saed Mirzadeh
    Rafał Rola
    Adrian Merlo
    Alfred Morgenstern
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 614 - 622
  • [4] Safety and efficacy of targeted alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastoma
    Krolicki, Leszek
    Bruchertseifer, Frank
    Kunikowska, Jolanta
    Koziara, Henryk
    Krolicki, Bartosz
    Jakucinski, Maciej
    Pawlak, Dariusz
    Apostolidis, Christos
    Mirzadeh, Saed
    Rola, Rafal
    Merlo, Adrian
    Morgenstern, Alfred
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (03) : 614 - 622
  • [5] Recurrent glioblastoma multiforme - local alpha emiters targeted therapy with 213Bi-DOTA-substance P
    Krolicki, L.
    Morgenstern, A.
    Kunikowska, J.
    Koziara, H.
    Krolicki, B.
    Jakucinski, M.
    Pawlak, D.
    Apostolidis, C.
    Bruchertseifer, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S84 - S85
  • [6] Alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastoma multiforme
    Krolicki, Leszek
    Morgenstern, Alfred
    Kunikowska, Jolanta
    Koziara, Henryk
    Krolicki, Bartosz
    Jakucinski, Maciej
    Pawlak, Dariusz
    Apostolidis, Christos
    Bruchertseifer, Frank
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [7] Secondary glioblastoma multiforme - local alpha emiters targeted therapy with 213Bi-DOTA-substance P
    Krolicki, L.
    Morgenstern, A.
    Kunikowska, J.
    Koziara, H.
    Krolicki, B.
    Jakucinski, M.
    Pawlak, D.
    Apostolidis, C.
    Bruchertseifer, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S158 - S158
  • [8] Routine preparation of 68Ga-DOTA-Substance P doses for locoregional administration follow up of 213Bi-DOTA-Substance P in the course of glioma therapy
    Pawlak, D.
    Kunikowska, J.
    Krolicki, L.
    Kopatys, A.
    Garnuszek, W. Tkacz
    Maurin, M.
    Mikolajczak, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S512 - S512
  • [9] Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial
    D. Cordier
    F. Forrer
    F. Bruchertseifer
    A. Morgenstern
    C. Apostolidis
    S. Good
    J. Müller-Brand
    H. Mäcke
    J. C. Reubi
    A. Merlo
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 1335 - 1344
  • [10] Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial
    Cordier, D.
    Forrer, F.
    Bruchertseifer, F.
    Morgenstern, A.
    Apostolidis, C.
    Good, S.
    Mueller-Brand, J.
    Maecke, H.
    Reubi, J. C.
    Merlo, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (07) : 1335 - 1344
1234